March 24, 2021
Everlywell, a leader in the at-home diagnostic testing space, has acquired PWNHealth and its subsidiary Home Access Health to form a new parent company called Everly Health.
PWNHealth and Home Access Health both have self-collected lab test services, and by combining the companies, Everly Health will support more than 20 million people annually in all 50 U.S. states, Canada and Puerto Rico,...
February 25, 2021
The digital health ecosystem has swelled to encompass a broad range of products over the years.
On one end of the spectrum is software-as-medical-devices (SaMD) and prescription digital therapeutics, product categories for which a comprehensive regulatory strategy and engagement with the FDA are mandatory. On the other are wellness apps and other low-risk digital tools that likely spend more time...
February 18, 2021
A facelift for hospital room TVs. Amwell announced today a new tech addition to the company's hospital-focused telehealth product. Specifically, the company's Hospital TV 100 kit transforms a hospital room's existing television into a two-way video conversation with virtual providers – an approach that Amwell said will allow hospitals to leverage their existing infrastructure to scale their...
December 3, 2020
Everlywell, a digital consumer platform for ordering and viewing lab tests from home, has closed an oversubscribed $175 million Series D funding round, the Austin, Texas-based company announced this morning.
The raise brought in a slew of new investors hailing from BlackRock, the Chernin Group, Foresite Capital, Greenspring Associates, Lux Capital, Morningside Ventures and Portfolia. It also saw...
May 19, 2020
Austin, Texas-based EverlyWell, a digital platform that lets consumers order lab tests online and view their results, has received an FDA Emergency Use Authorization (EUA) for a COVID-19 at-home diagnostic sample collection kit that can be used with multiple diagnostic lab tests.
Announced Friday by the FDA and Monday by the startup, the EverlyWell COVID-19 Test Home Collection Kit includes nasal...
March 23, 2020
Last week saw a number of diagnostic testing startups, telehealth providers and others announce new services that would deliver at-home COVID-19 testing-kits to consumers. But the majority of these of offerings have since been rescinded or hang in doubt thanks to new warnings and regulatory clarifications issued this weekend by the FDA.
On Friday evening, the agency released an alert to consumers...
March 19, 2020
Editor's note: Since the publication of this story, the FDA has issued an alert warning that it "has not authorized any test that is available to purchase for testing yourself at home for COVID-19." Nurx and others have halted their at-home testing COVID-19 services in response: read the updated story here.
The shortage of coronavirus testing kits in the United States has quickly come to the...
September 6, 2019
Consumer healthcare businesses can describe their work a lot of ways: as wellness, as disease prevention or as healthcare outside the traditional health system. Or there's biohacking, a term that has emerged to describe all kinds of ways individuals can optimize their own health in the same way that tech-saavy folks optimize their computers.
At the annual Health 2.0 Fall Conference this month in...
May 29, 2019
Even as Amazon ramps up its marketing efforts for PillPack, potential competitor Blink Health is hoping to get ahead with the announcement of three new hires — from Amazon.
Bharath Chinamanthur, Blink’s new EVP of engineering and operations, spent 11 years in leadership roles at Amazon. Christopher Plambeck, who joins as SVP of data sciences and monetization, spent five years at Amazon and...
April 16, 2019
Austin, Texas-based EverlyWell – maker of a digital platform that lets consumers order lab tests online, provide samples and receive results – has raised $50 million in a funding round announced this morning. Goodwater Capital led the round, with additional participation from Highland Capital Partners, Next Coast Ventures, NextGen Venture Partners and other unnamed investors.
WHAT THEY DO...